If the source person's HIV screening test result is negative but there has been a risk for HIV exposure in the previous 6 weeks, plasma HIV RNA testing of the source person is also recommended. In ...
Pharmacy students in the U.S. show limited knowledge of HIV prophylaxis, especially PEP, due to inadequate assessment tools. Pharmacists are pivotal in HIV prevention, but their knowledge of PrEP and ...
In pregnant women testing negative for HIV, second-trimester preexposure prophylaxis with the dapivirine vaginal ring or oral tenofovir disoproxil fumarate-emtricitabine is safe.
HIV pre-exposure prophylaxis (PrEP) is a prevention strategy which includes the regular or event-driven use of antiretroviral medication to prevent HIV infection in adults. Several clinical trials ...
Single pills (brand name Truvada) containing two antiretroviral drugs, emtricitabine (TFC) and tenofovir disoproxyl fumarate (TDF), used for pre-exposure prophylaxis, or PrEP. Connecticut minors are ...
"When newborns aren't getting preventive treatment, it suggests we may be missing HIV infections in pregnant women." HealthDay News — Although the rate of perinatal HIV infection is low, more than 50% ...
HealthDay News — Although the rate of perinatal HIV infection is low, more than 50% of HIV infections in infants before age 1 year occurred in those who did not receive postnatal prophylaxis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results